动脉瘤性蛛网膜下腔出血后迟发性脑缺血的2010年共识定义预后价值
该单中心回顾性观察研究纳入2010年1月至2014年12月入住ICU的340例连续成年动脉瘤性蛛网膜下腔出血患者,采用2010年共识标准在症状发作后48小时至14天评估迟发性脑缺血,出院时以格拉斯哥结局量表评估预后。迟发性脑缺血发生率为37.1%,从原发出血到发生迟发性脑缺血的中位时间为97小时,符合迟发性脑缺血标准的患者中89.7%观察到神经功能恶化。迟发性脑缺血的发生与出院时不良结局(GOS 1-3分)强相关(OR 2.65,95%CI 1.69-4.22,p<0.001)。作者认为迟发性脑缺血是影响动脉瘤性蛛网膜下腔出血幸存者功能能力的主要因素,未来研究应遵循迟发性脑缺血的共识定义。
要点
- 340例动脉瘤性蛛网膜下腔出血患者中迟发性脑缺血发生率为37.1%,从原发出血到发生迟发性脑缺血的中位时间为97小时。
- 符合迟发性脑缺血标准的患者中89.7%出现神经功能恶化。
- 迟发性脑缺血与出院时不良结局(GOS 1-3分)强相关:OR 2.65,95%CI 1.69-4.22,p<0.001。
- 迟发性脑缺血评估窗口为症状发作后48小时至14天,采用2010年共识标准。
适用人群与场景
- 2010年1月至2014年12月入住ICU的连续成年动脉瘤性蛛网膜下腔出血患者。
诊断标准与关键阈值
- 采用2010年共识标准评估迟发性脑缺血,评估时间为动脉瘤性蛛网膜下腔出血症状发作后48小时至14天。
红旗征与不能漏的情况
- 符合迟发性脑缺血标准的患者中89.7%出现神经功能恶化。
研究设计与关键结果
- 单中心、回顾性、观察性研究,纳入340例连续成年动脉瘤性蛛网膜下腔出血患者,迟发性脑缺血发生率为37.1%。
- 从原发出血到发生迟发性脑缺血的中位时间为97小时。
- 迟发性脑缺血与出院时不良结局(GOS 1-3分)强相关:OR 2.65,95%CI 1.69-4.22,p<0.001。
证据类型、等级与局限
- 单中心、回顾性、观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为迟发性脑缺血似乎是影响动脉瘤性蛛网膜下腔出血幸存者功能能力的主要因素。
- 作者认为未来研究应遵循迟发性脑缺血的共识定义。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Delayed cerebral ischemia (DCI) complicates the recovery of approximately 30% of patients with aneurysmal subarachnoid hemorrhage (aSAH). The definition of DCI widely varies, even though a consensus definition has been recommended since 2010. This study aimed to evaluate the prognostic value of the 2010 consensus definition of DCI in a cohort of patients with aSAH.
METHODS: We conducted a single-center, retrospective, observational study that included consecutive adult patients with aSAH who were admitted to the intensive care unit from January 2010 to December 2014. DCI was evaluated 48 h to 14 days after onset of aSAH symptoms using the 2010 consensus criteria and outcome was assessed by the Glasgow Outcome Scale (GOS) at discharge from hospital.
RESULTS: A total of 340 patients were analyzed and the incidence of DCI was 37.1%. The median time from primary hemorrhage to the occurrence of DCI was 97 h. Neurological deterioration was observed in most (89.7%) of the patients who fulfilled the DCI criteria. The occurrence of DCI was strongly associated with an unfavorable outcome (GOS 1-3) at hospital discharge (OR 2.65, 95% CI 1.69-4.22, p < 0.001).
CONCLUSIONS: The incidence of DCI after aSAH is high and its occurrence is strongly associated with an unfavorable neurological outcome. This finding adds to the previous literature, which has shown that DCI appears to be a major contributor affecting the functional ability of survivors of aSAH. To further advance reliable knowledge of DCI, future studies should adhere to the consensus definition of DCI.
参考来源
- Raatikainen E, Vahtera A, Kuitunen A, et al. Prognostic value of the 2010 consensus definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurol Sci. 2020. PMID: 33316615. doi:10.1016/j.jns.2020.117261
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。